Tag: NASDAQ: ETON

Business

Eton Pharmaceuticals Inc (NASDAQ: ETON) Gains FDA Endorsement For Recipes

Eton Pharmaceuticals Inc (NASDAQ: ETON) announced that the U.S. Food and Drug Administration (FDA) has accepted Rezipres® (ephedrine hydrochloride injection) for the treatment of clinically vital hypotension happening in the background of anesthesia. The company shares were up 7.06% at $6.98 on Tuesday. “We are happy to see the consent […]